424 related articles for article (PubMed ID: 28288987)
1. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.
Besler C; Lang D; Urban D; Rommel KP; von Roeder M; Fengler K; Blazek S; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28288987
[TBL] [Abstract][Full Text] [Related]
2. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
[TBL] [Abstract][Full Text] [Related]
4. Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation.
Noguchi K; Tomita H; Kanayama T; Niwa A; Hatano Y; Hoshi M; Sugie S; Okada H; Niwa M; Hara A
PLoS One; 2019; 14(1):e0210971. PubMed ID: 30673749
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Galectin-3 as a Novel Biomarker for Chagas Cardiomyopathy.
Noya-Rabelo MM; Larocca TF; Macêdo CT; Torreão JA; Souza BS; Vasconcelos JF; Souza LE; Silva AM; Ribeiro Dos Santos R; Correia LC; Soares MB
Cardiology; 2017; 136(1):33-39. PubMed ID: 27548475
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction.
Hoshino S; Shimizu C; Jain S; He F; Tremoulet AH; Burns JC
J Am Heart Assoc; 2020 Jan; 9(1):e014569. PubMed ID: 31880981
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms.
Numano F; Shimizu C; Jimenez-Fernandez S; Vejar M; Oharaseki T; Takahashi K; Salgado A; Tremoulet AH; Gordon JB; Burns JC; Daniels LB
Int J Cardiol; 2015 Dec; 201():429-37. PubMed ID: 26313861
[TBL] [Abstract][Full Text] [Related]
8. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
[TBL] [Abstract][Full Text] [Related]
9. Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.
Gopal DM; Kommineni M; Ayalon N; Koelbl C; Ayalon R; Biolo A; Dember LM; Downing J; Siwik DA; Liang CS; Colucci WS
J Am Heart Assoc; 2012 Oct; 1(5):e000760. PubMed ID: 23316284
[TBL] [Abstract][Full Text] [Related]
10. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.
Krejci J; Hude P; Poloczkova H; Zampachova V; Stepanova R; Freiberger T; Nemcova E; Spinarova L
Heart Vessels; 2016 Mar; 31(3):416-26. PubMed ID: 25539624
[TBL] [Abstract][Full Text] [Related]
11. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy.
Vergaro G; Del Franco A; Giannoni A; Prontera C; Ripoli A; Barison A; Masci PG; Aquaro GD; Cohen Solal A; Padeletti L; Passino C; Emdin M
Int J Cardiol; 2015 Apr; 184():96-100. PubMed ID: 25697876
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.
Nguyen MN; Su Y; Vizi D; Fang L; Ellims AH; Zhao WB; Kiriazis H; Gao XM; Sadoshima J; Taylor AJ; McMullen JR; Dart AM; Kaye DM; Du XJ
Sci Rep; 2018 May; 8(1):8213. PubMed ID: 29844319
[TBL] [Abstract][Full Text] [Related]
15. Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction.
Grupper A; Nativi-Nicolau J; Maleszewski JJ; Geske JR; Kremers WK; Edwards BS; Kushwaha SS; Pereira NL
JACC Heart Fail; 2016 Nov; 4(11):847-856. PubMed ID: 27614937
[TBL] [Abstract][Full Text] [Related]
16. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
[TBL] [Abstract][Full Text] [Related]
17. [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
Kuhn H; Lawrenz T; Beer G
Med Klin (Munich); 2005 Sep; 100(9):553-61. PubMed ID: 16170644
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
[TBL] [Abstract][Full Text] [Related]
19. The potential role of plasma miR-155 and miR-206 as circulatory biomarkers in inflammatory cardiomyopathy.
Obradovic D; Rommel KP; Blazek S; Klingel K; Gutberlet M; Lücke C; Büttner P; Thiele H; Adams V; Lurz P; Emrich F; Besler C
ESC Heart Fail; 2021 Jun; 8(3):1850-1860. PubMed ID: 33830643
[TBL] [Abstract][Full Text] [Related]
20. Right Ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients.
Nippoldt TB; Edwards WD; Holmes DR; Reeder GS; Hartzler GO; Smith HC
Mayo Clin Proc; 1982 Jul; 57(7):407-18. PubMed ID: 6211578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
